Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $405 | $255 | $77 | $61 |
| - Cash | $57 | $91 | $36 | $30 |
| + Debt | $57 | $54 | $58 | $54 |
| Enterprise Value | $405 | $218 | $99 | $85 |
| Revenue | $77 | $63 | $42 | $51 |
| % Growth | 22% | 49.8% | -17.1% | – |
| Gross Profit | $42 | $35 | $22 | $26 |
| % Margin | 55.2% | 55.5% | 52.9% | 50.6% |
| EBITDA | -$31 | -$14 | -$12 | -$26 |
| % Margin | -40.9% | -22.5% | -28.3% | -51.7% |
| Net Income | -$40 | -$25 | -$23 | -$27 |
| % Margin | -51.8% | -39.2% | -53.8% | -54.1% |
| EPS Diluted | -0.98 | -0.82 | -0.99 | -1.27 |
| % Growth | -19.5% | 17.2% | 22% | – |
| Operating Cash Flow | -$31 | -$14 | -$21 | -$26 |
| Capital Expenditures | -$3 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$34 | -$16 | -$21 | -$27 |